Loading...
•
Sep 30, 2025
Puma Biotechnology Q3 2025 Earnings Report
Puma Biotechnology reported its third quarter 2025 financial results, highlighting a decrease in net income and total revenue compared to the previous year, despite an increase in U.S. sales of NERLYNX®.
Key Takeaways
Puma Biotechnology reported a net income of $8.8 million for Q3 2025, a significant decrease from $20.3 million in Q3 2024. Total revenue also declined to $54.5 million from $80.5 million in the prior year, primarily due to reduced international product supply revenue and lower royalty revenue, partially offset by increased U.S. NERLYNX® sales.
Net income for Q3 2025 was $8.8 million, down from $20.3 million in Q3 2024.
Total revenue for Q3 2025 was $54.5 million, a decrease from $80.5 million in Q3 2024.
Product revenue, net, decreased to $51.9 million in Q3 2025 from $56.1 million in Q3 2024, mainly due to lower international sales and higher gross-to-net adjustments.
Non-GAAP adjusted net income was $10.5 million for Q3 2025, compared to $22.4 million for Q3 2024.
Revenue by Segment
Forward Guidance
Puma Biotechnology has raised its full-year 2025 NERLYNX® revenue and net income estimates, anticipating continued positive earnings trends driven by increased demand for NERLYNX®.
Positive Outlook
- Updated full-year 2025 net product revenue guidance increased to $198–$200 million from $192–$198 million.
- Updated full-year 2025 royalty revenue guidance increased to $22–$23 million from $20–$24 million.
- Updated full-year 2025 total revenue guidance increased to $220–$223 million from $212–$222 million.
- Updated full-year 2025 net income guidance increased to $27–$29 million from $23–$28 million.
- Anticipates 2025 to be the first year-over-year demand increase for NERLYNX in the United States since 2018.
Challenges Ahead
- Fourth quarter 2025 net product revenue is projected to be $54–$56 million, which is lower than the previous quarter's product revenue.
- Fourth quarter 2025 royalty revenue is projected to be $13–$14 million, which is higher than the current quarter but still subject to market dynamics.
Historical Earnings Impact
Analyze how earnings announcements historically affect stock price performance
Avg. Return Before/After Earnings
Loading earnings performance data...
Loading earnings reaction data...